Trial Profile
Effectiveness of Long-Acting Risperidone in the Maintenance Treatment of First-Episode Schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2012
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Antipsychotics
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms PREFER
- 29 Sep 2012 Status changed from active, no longer recruiting to completed based on publication of results.
- 07 Aug 2012 2-Year results published in the Journal of Clinical Psychiatry.
- 01 Oct 2009 Results published in the Journal of Clinical Psychiatry.